The platform will only allow for advertisements for stem cell therapy treatments that are approved by the FDA and will also allow gene and cell therapy ads for products that aren’t FDA approved if they are “exclusively educational or informational in nature”.
While there are 23 FDA approved stem cell treatments, many other treatments are unproven and potentially dangerous.
“Google’s continuing stem cell problem is emblematic of a serious, broader problem with unproven biomedical offerings the company needs to address,” said Paul Knoepfler, PhD, a professor at the UC Davis School of Medicine in Sacramento.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
